COVID-19 and functional disability: current insights and rehabilitation strategies
Pasquale Ambrosino, Antimo Papa, Mauro Maniscalco, Matteo Nicola Dario Di Minno
Abstract
L Hansson, LH Lindholm, L Niskanen, et al.., for the Captopril Prevention Project (CAPPP) study group. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet. 1999 Feb 20;353:611–6.
Topics & Concepts
MedicineCaptoprilCoronavirus disease 2019 (COVID-19)RehabilitationAngiotensin-converting enzymeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPhysical therapyInternal medicineIntensive care medicineVirologyDiseaseBlood pressureOutbreakInfectious disease (medical specialty)Intensive Care Unit Cognitive DisordersLong-Term Effects of COVID-19Respiratory Support and Mechanisms